RenovaCare $2M Deal, RenovaCare stock promotion lawsuit, securities class action, SkinGun, StreetAuthority

The case underscores the complexities of securities litigation and highlights the risks companies face when engaging in questionable promotional practices. The $2 million settlement offers some relief to the investors, though the case serves as a cautionary tale of the potential pitfalls in the biotech industry.